1. Home
  2. INZY vs ELTK Comparison

INZY vs ELTK Comparison

Compare INZY & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • ELTK
  • Stock Information
  • Founded
  • INZY 2015
  • ELTK 1970
  • Country
  • INZY United States
  • ELTK Israel
  • Employees
  • INZY N/A
  • ELTK N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • ELTK Electrical Products
  • Sector
  • INZY Health Care
  • ELTK Technology
  • Exchange
  • INZY Nasdaq
  • ELTK Nasdaq
  • Market Cap
  • INZY 64.9M
  • ELTK 57.5M
  • IPO Year
  • INZY 2020
  • ELTK 1997
  • Fundamental
  • Price
  • INZY $0.92
  • ELTK $8.53
  • Analyst Decision
  • INZY Strong Buy
  • ELTK
  • Analyst Count
  • INZY 9
  • ELTK 0
  • Target Price
  • INZY $17.22
  • ELTK N/A
  • AVG Volume (30 Days)
  • INZY 453.8K
  • ELTK 8.1K
  • Earning Date
  • INZY 05-06-2025
  • ELTK 05-20-2025
  • Dividend Yield
  • INZY N/A
  • ELTK 2.23%
  • EPS Growth
  • INZY N/A
  • ELTK N/A
  • EPS
  • INZY N/A
  • ELTK 0.63
  • Revenue
  • INZY N/A
  • ELTK $46,527,000.00
  • Revenue This Year
  • INZY N/A
  • ELTK $18.60
  • Revenue Next Year
  • INZY N/A
  • ELTK $9.04
  • P/E Ratio
  • INZY N/A
  • ELTK $13.54
  • Revenue Growth
  • INZY N/A
  • ELTK N/A
  • 52 Week Low
  • INZY $0.72
  • ELTK $7.65
  • 52 Week High
  • INZY $6.24
  • ELTK $12.47
  • Technical
  • Relative Strength Index (RSI)
  • INZY 44.29
  • ELTK 45.32
  • Support Level
  • INZY $0.83
  • ELTK $8.39
  • Resistance Level
  • INZY $1.08
  • ELTK $8.71
  • Average True Range (ATR)
  • INZY 0.11
  • ELTK 0.32
  • MACD
  • INZY 0.02
  • ELTK 0.14
  • Stochastic Oscillator
  • INZY 55.43
  • ELTK 83.02

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

Share on Social Networks: